The bleeding risk during warfarin therapy is associated with the number of variant alleles of CYP2C9 and VKORC1 genes

Aleš Tomek, Václav Maťoška, Tereza Kolářová, Jiří Neumann, Martin Šrámek, Ivana Šarbochová, Luděk Táborský, Martin Bojar, Petr Goetz, Victor L. Serebruany

Research output: Contribution to journalArticlepeer-review

16 Scopus citations

Fingerprint

Dive into the research topics of 'The bleeding risk during warfarin therapy is associated with the number of variant alleles of CYP2C9 and VKORC1 genes'. Together they form a unique fingerprint.

Medicine & Life Sciences